Literature DB >> 2022511

Planning of radiotherapy for patients with hip prosthesis.

M Erlanson1, L Franzén, R Henriksson, B Littbrand, P O Löfroth.   

Abstract

The effects of a hip prosthesis on the dose distribution when treating pelvic cancer have been evaluated. A prosthesis of titanium alloy in a water phantom was used as a model. Photon radiation beams with energies of 6, 20, and 50 MV and with a focus phantom distance of 100 cm were directed against the prosthesis. The dose profiles at different depths were measured with the RFA-7 system. The sphere of the prosthesis was inhomogeneous. The dose in a beam behind the prosthesis was reduced with the order of 10-40% and the largest distortion was behind the shaft. Using an opposed four-field technique with the same weight on all the fields, the dose reduction was as large as 7-12% in a string across the target behind the end of the shaft. With 50% weight on the lateral fields, the dose reduction was 4-8% of the average dose. Such an uneven dose distribution may decrease the curability, and a treatment technique not including the prosthesis should be preferred. Finally, a local increase of the dose close to the prosthesis seems to be of limited practical concern even at the highest energies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022511     DOI: 10.1016/0360-3016(91)90210-u

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Dose attenuation effect of hip prostheses in a 9-MV photon beam: commercial treatment planning system versus Monte Carlo calculations.

Authors:  Asghar Mesbahi; Farshad Seyed Nejad
Journal:  Radiat Med       Date:  2007-12-25

Review 2.  Computed tomography imaging parameters for inhomogeneity correction in radiation treatment planning.

Authors:  Indra J Das; Chee-Wai Cheng; Minsong Cao; Peter A S Johnstone
Journal:  J Med Phys       Date:  2016 Jan-Mar

3.  An opposed matched field IMRT technique for prostate cancer patients with bilateral prosthetic hips.

Authors:  Shahin Fattahi; Orest Z Ostapiak
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

4.  Impact of the Tiloop Bra® mesh in CT images and dose delivery in breast radiotherapy.

Authors:  Cristina Camacho; M Carmen Pujades; Jose Perez-Calatayud; Françoise Lliso; Vicente Carmona; Alejandro Tormo; Facundo Ballester
Journal:  J Appl Clin Med Phys       Date:  2012-03-08       Impact factor: 2.102

5.  Dose comparison between Gafchromic film, XiO, and Monaco treatment planning systems in a novel pelvic phantom that contains a titanium hip prosthesis.

Authors:  Nicholas Ade; F C P du Plessis
Journal:  J Appl Clin Med Phys       Date:  2017-07-25       Impact factor: 2.102

6.  Evaluation of dose calculation accuracy of treatment planning systems at hip prosthesis interfaces.

Authors:  David Paulu; Parham Alaei
Journal:  J Appl Clin Med Phys       Date:  2017-03-20       Impact factor: 2.102

7.  Study of dosimetric properties of flattened and unflattened megavoltage x ray beam on high Z implant materials.

Authors:  Tamilarasan Rajamanickam; Sivakumar Muthu; Perumal Murugan; Muddappa Pathokonda; Krishnamoorthy Senthilnathan; Narayanasamy Arunai Nambi Raj; Padmanabhan Ramesh Babu
Journal:  J Appl Clin Med Phys       Date:  2018-09-28       Impact factor: 2.102

8.  A radiotherapy technique to improve dose homogeneity around bone prostheses.

Authors:  M V Williams; N G Burnet; E Sherwin; R Kestelman; A R Geater; S J Thomas; C B Wilson
Journal:  Sarcoma       Date:  2004

9.  A dosimetric study of volumetric modulated arc therapy planning techniques for treatment of low-risk prostate cancer in patients with bilateral hip prostheses.

Authors:  Suresh B Rana; Shyam Pokharel
Journal:  South Asian J Cancer       Date:  2014-01

10.  A Monte Carlo study on electron and neutron contamination caused by the presence of hip prosthesis in photon mode of a 15 MV Siemens PRIMUS linac.

Authors:  Mohammad Taghi Bahreyni Toossi; Marziyeh Behmadi; Mahdi Ghorbani; Hamid Gholamhosseinian
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.